Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
TerminatedPhase 4NCT00236327
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to determine the safety and efficacy of pain control by fentanyl, administered via adhesive skin patches, at doses of 25 to 100 micrograms per hour in 80 out-patients with intense chronic cancer pain. Higher doses are allowed by permission of the investigator and rescue oral morphine medication is allowed.
Study details
- Official title
- Evaluation of the Efficacy and Safety of Transdermal Fentanyl in Patients Suffering From Chronic Cancer Pain in an Ambulatory Setting
- Conditions
- Interventions
- Sponsor
- Janssen Cilag S.A.S.
- Start date
- 2003-06
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Less than a month of opioid treatment over the past 3 months * Proven cancer and chronic stable, cancer-related pain * Pain control medication (aside from opioids) at the maximum authorized dose in the 24-hours preceding the first study visit * A pain score of at least 4 on the VAS scale and pain that justifies intervention by opium-derived drugs in the opinion of the investigator Exclusion Criteria: * Liver or kidney problems * Previous heart, lung or nervous disorders * Allergy to fentanyl * Skin condition that might interfere with absorption of the fentanyl through the skin * Surgery or chemotherapy in the month preceding the study or scheduled during the 56 days of the study * History of substance abuse
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00236327